Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases.

De Caneva A, Porro F, Bortolussi G, Sola R, Lisjak M, Barzel A, Giacca M, Kay MA, Vlahoviček K, Zentilin L, Muro AF.

JCI Insight. 2019 Jun 18;5. pii: 128863. doi: 10.1172/jci.insight.128863.

2.

Stroke patients' and non-professional coaches' experiences with home-based constraint-induced movement therapy: a qualitative study.

Stark A, Färber C, Tetzlaff B, Scherer M, Barzel A.

Clin Rehabil. 2019 May 20:269215519848813. doi: 10.1177/0269215519848813. [Epub ahead of print]

PMID:
31104476
3.

New Horizons for Immune Gene Therapy.

Barzel A, Flotte TR.

Hum Gene Ther. 2019 Apr;30(4):379-380. doi: 10.1089/hum.2019.29085.aba. No abstract available.

PMID:
30950655
4.
5.

The German version of the Functional Walking Categories (FWC): translation and initial validation.

Klotz SGR, Petersen-Ewert C, Ketels G, Scherer M, Barzel A.

Top Stroke Rehabil. 2019 Jan;26(1):49-57. doi: 10.1080/10749357.2018.1536022. Epub 2018 Oct 22.

PMID:
30346912
6.

Protection against the overuse and underuse of health care - methodological considerations for establishing prioritization criteria and recommendations in general practice.

Muche-Borowski C, Abiry D, Wagner HO, Barzel A, Lühmann D, Egidi G, Kühlein T, Scherer M.

BMC Health Serv Res. 2018 Oct 11;18(1):768. doi: 10.1186/s12913-018-3569-9.

7.

[Early detection of atrial fibrillation in patients at risk].

Barzel A, Scherer M.

MMW Fortschr Med. 2018 Aug;160(14):50-52. doi: 10.1007/s15006-018-0826-0. Review. German. No abstract available.

PMID:
30105690
8.

Immune Gene Therapy and the International Conference on Lymphocyte Engineering (ICLE 2018).

Barzel A.

Hum Gene Ther. 2018 Jun;29(6):vii-ix. doi: 10.1089/hum.2018.29069.aba. No abstract available.

PMID:
29902085
9.

Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.

Borel F, Tang Q, Gernoux G, Greer C, Wang Z, Barzel A, Kay MA, Shultz LD, Greiner DL, Flotte TR, Brehm MA, Mueller C.

Mol Ther. 2017 Nov 1;25(11):2477-2489. doi: 10.1016/j.ymthe.2017.09.020. Epub 2017 Sep 25.

10.

Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model.

Porro F, Bortolussi G, Barzel A, De Caneva A, Iaconcig A, Vodret S, Zentilin L, Kay MA, Muro AF.

EMBO Mol Med. 2017 Oct;9(10):1346-1355. doi: 10.15252/emmm.201707601.

11.

A universal system to select gene-modified hepatocytes in vivo.

Nygaard S, Barzel A, Haft A, Major A, Finegold M, Kay MA, Grompe M.

Sci Transl Med. 2016 Jun 8;8(342):342ra79. doi: 10.1126/scitranslmed.aad8166.

12.

Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial.

Barzel A, Ketels G, Stark A, Tetzlaff B, Daubmann A, Wegscheider K, van den Bussche H, Scherer M.

Lancet Neurol. 2015 Sep;14(9):893-902. doi: 10.1016/S1474-4422(15)00147-7. Epub 2015 Jul 28.

PMID:
26231624
13.

Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.

Barzel A, Paulk NK, Shi Y, Huang Y, Chu K, Zhang F, Valdmanis PN, Spector LP, Porteus MH, Gaensler KM, Kay MA.

Nature. 2015 Jan 15;517(7534):360-4. doi: 10.1038/nature13864. Epub 2014 Oct 29.

14.

[Quo vadis Therapeutic Health Care Professionals--What do Occupational and Physical Therapists Think about their Future? Results of a Survey throughout Germany].

Ketels G, Schön G, van den Bussche H, Barzel A.

Gesundheitswesen. 2015 Nov;77(11):e172-8. doi: 10.1055/s-0034-1387711. Epub 2014 Sep 30. German.

PMID:
25268413
15.

Enhancing activities of daily living of chronic stroke patients in primary health care by modified constraint-induced movement therapy (HOMECIMT): study protocol for a cluster randomized controlled trial.

Barzel A, Ketels G, Tetzlaff B, Krüger H, Haevernick K, Daubmann A, Wegscheider K, Scherer M.

Trials. 2013 Oct 14;14:334. doi: 10.1186/1745-6215-14-334.

16.

Can a brief two-hour interdisciplinary communication skills training be successful in undergraduate medical education?

Bachmann C, Barzel A, Roschlaub S, Ehrhardt M, Scherer M.

Patient Educ Couns. 2013 Nov;93(2):298-305. doi: 10.1016/j.pec.2013.05.019. Epub 2013 Jun 24.

PMID:
23806818
17.

[The Quality indicator project of the German college of general practice and family medicine (DEGAM): development of indicators based on the guidelines dementia, neck pain and sore throat].

Scherer M, Wollny A, Vollmar HC, Chenot JF, Baum E, Barzel A, Beyer M, Egidi G, Kaufmann-Kolle P, Mainz A, Popert U, Schmiemann G, Voigt K, Wagner HO, Szecsenyi J.

Z Evid Fortbild Qual Gesundhwes. 2013;107(1):74-86. doi: 10.1016/j.zefq.2012.11.016. Epub 2012 Dec 7. German.

PMID:
23415347
18.

Home and away- the evolutionary dynamics of homing endonucleases.

Barzel A, Obolski U, Gogarten JP, Kupiec M, Hadany L.

BMC Evol Biol. 2011 Nov 4;11:324. doi: 10.1186/1471-2148-11-324.

19.

Native homing endonucleases can target conserved genes in humans and in animal models.

Barzel A, Privman E, Peeri M, Naor A, Shachar E, Burstein D, Lazary R, Gophna U, Pupko T, Kupiec M.

Nucleic Acids Res. 2011 Aug;39(15):6646-59. doi: 10.1093/nar/gkr242. Epub 2011 Apr 27.

20.

In vivo characterization of the homing endonuclease within the polB gene in the halophilic archaeon Haloferax volcanii.

Naor A, Lazary R, Barzel A, Papke RT, Gophna U.

PLoS One. 2011 Jan 20;6(1):e15833. doi: 10.1371/journal.pone.0015833.

21.

Homing endonucleases residing within inteins: evolutionary puzzles awaiting genetic solutions.

Barzel A, Naor A, Privman E, Kupiec M, Gophna U.

Biochem Soc Trans. 2011 Jan;39(1):169-73. doi: 10.1042/BST0390169. Review.

PMID:
21265767
22.

Comparison of two types of Constraint-Induced Movement Therapy in chronic stroke patients: A pilot study.

Barzel A, Liepert J, Haevernick K, Eisele M, Ketels G, Rijntjes M, van den Bussche H.

Restor Neurol Neurosci. 2009;27(6):673-80. doi: 10.3233/RNN-2009-0524.

PMID:
20042791
23.

Repeat therapy for chronic motor stroke: a pilot study for feasibility and efficacy.

Rijntjes M, Haevernick K, Barzel A, van den Bussche H, Ketels G, Weiller C.

Neurorehabil Neural Repair. 2009 Mar-Apr;23(3):275-80. doi: 10.1177/1545968308324226. Epub 2008 Nov 18.

PMID:
19017785
24.

[Outpatient management of stroke patients from the viewpoint of general practitioners in Hamburg--an exploratory study].

Barzel A, Eisele M, Bussche Hv.

Gesundheitswesen. 2008 Mar;70(3):170-6. doi: 10.1055/s-2008-1062731. German.

PMID:
18415925
25.

Finding a match: how do homologous sequences get together for recombination?

Barzel A, Kupiec M.

Nat Rev Genet. 2008 Jan;9(1):27-37. Review.

PMID:
18040271
26.

The surround inhibition determines therapy-induced cortical reorganization.

Liepert J, Haevernick K, Weiller C, Barzel A.

Neuroimage. 2006 Sep;32(3):1216-20. Epub 2006 Jun 30.

PMID:
16809053
27.

[Conception, implementation and evaluation of the new general medicine continuing education curriculum in Südbaden].

Härter M, Nolte J, Mack-Hennes A, Niebling W, Barzel A, Schröder P, Luckner AV, Ziegler V.

Z Arztl Fortbild (Jena). 1996 Aug;90(5):400-5. German.

PMID:
9157731

Supplemental Content

Loading ...
Support Center